Breaking down regulatory barriers could deliver step change improvements to prostate cancer outcomes 21 Mar 2023 We have seen major advances in prostate cancer research, and people with the disease are living longer than ever. However, more needs to be done to harness scientific discoveries and bring innovative drugs to patients. Here we discuss the regulatory landscape and reforms needed to ensure patients can access the most innovative treatments as quickly as possible. Find out more Show/Hide
The exciting potential of radioactive elements in cancer treatment 08 Feb 2022 The element lutetium has made headlines around the world recently. In its radioactive ‘Lu-177’ form, as part of the drug Lu-177-PSMA, it has exciting potential as a cancer treatment – as our researchers here at The Institute of Cancer Research have helped to demonstrate. So how does it work – and what other radioactive elements have been used as cancer treatments? Find out more Show/Hide